Drag a card by its title · ⚙ to size, swap or remove

The company

Beta Bionics, Inc.

BBNX · Nasdaq

Health CareMedical DevicesIn trend

BBNX stood above a rising 150-day average in 18 of the last 52 weekly readings, including each of the last 7 weeks. It is 28.4% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: In trend
Weeks in an uptrend: 7 in a row
Industry in uptrend: 29% -2 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $10.5M
Officials’ trades on record: 0
Institutions holding: 131 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.

23 Apr – 22 Oct

Medical Devices: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months49

Buyers · sellers0 · 8

Who	Did	Shares	Traded
Mark HopmanChief Commercial Officer	sold	775at $17.35	14 Oct 2026filed 16 Oct 2026
Mark HopmanChief Commercial Officer	sold	370at $18.96	1 Oct 2026filed 5 Oct 2026
Christy JonesDirector	sold	6,430at $23.00	22 Sep 2026filed 23 Sep 2026
Mark HopmanChief Commercial Officer	sold	30,779at $20.13	16 Sep 2026filed 17 Sep 2026
Mike MensingerChief Product Officer	sold	2,650at $22.00	16 Sep 2026filed 17 Sep 2026
Mark HopmanChief Commercial Officer	sold	775at $15.52	14 Sep 2026filed 15 Sep 2026
Mark HopmanChief Commercial Officer	sold	36,870at $18.46	9 Sep 2026filed 10 Sep 2026
Mark HopmanChief Commercial Officer	sold	35,994at $18.46	9 Sep 2026filed 18 Sep 2026
Sean SaintPresident & CEO	sold	5,641at $20.08	3 Sep 2026filed 4 Sep 2026
Mark HopmanChief Commercial Officer	sold	5,327at $19.11	2 Sep 2026filed 3 Sep 2026
Mike MensingerChief Product Officer	sold	4,375at $19.11	2 Sep 2026filed 3 Sep 2026
Stephen FeiderChief Financial Officer	sold	6,675at $19.11	2 Sep 2026filed 3 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders131+3 on the quarter

New · exited32 · 27

Reported value$756.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
EVENTIDE ASSET MANAGEMENT, LLCadded · filed 14 Aug 2026	6,253,673$98.1M	+308,185+5.2%
Soleus Capital Management, L.P.added · filed 11 Aug 2026	4,393,714$68.8M	+39,213+0.9%
MORGAN STANLEYadded · filed 13 Aug 2026	4,266,822$66.9M	+39,188+0.9%
Sands Capital Alternatives, LLCunchanged · filed 13 Aug 2026	3,708,043$58.1M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	3,340,171$52.3M	+301,576+9.9%
Point72 Asset Management, L.P.reduced · filed 14 Aug 2026	2,254,683$35.3M	-270,357−10.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,782,346$27.9M	+54,369+3.1%
Vestal Point Capital, LPreduced · filed 14 Aug 2026	1,600,000$25.1M	-611,518−27.7%
RTW INVESTMENTS, LPreduced · filed 14 Aug 2026	1,500,000$23.5M	-500,000−25.0%
DEERFIELD MANAGEMENT COMPANY, L.P.unchanged · filed 14 Aug 2026	1,324,000$20.7M	00.0%